Literature DB >> 8783417

Trends in immunoglobulin G anticardiolipin antibodies in ten successful heparin-treated pregnancies.

A Ruffatti1, M P Scapinello, S Tonetto, L Di Lenardo, A Piccoli, P Grella, S Todesco.   

Abstract

The pregnancies of ten women, all with histories of at least two spontaneous abortions of unknown cause, were followed. All patients were positive for immunoglobulin (Ig) G anticardiolipin antibodies (aCL) and one also for IgM aCL, while none had lupus anticoagulant activity. During pregnancy, the patients were treated with calcium heparin in doses varying between 15,000 and 30,000 IU daily. IgG aCL were assayed on average at the 9th, 17th, 24th and 29th weeks of pregnancy and at the moment of delivery. Mean values of IgG aCL levels during the 10 pregnancies steadily fell as the pregnancies progressed, and this decrease was significant (r = 0.985, P = 0.002). All pregnancies terminated favourably, although delivery was brought forward in eight patients and six of the nine placentas examined showed signs of thrombotic events. We assume that a steady fall in IgG aCL levels during pregnancy may be considered as indicative of a favourable outcome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783417     DOI: 10.1007/bf01419949

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  16 in total

Review 1.  Recurrent adverse pregnancy outcome and antiphospholipid antibodies.

Authors:  E A Reece; S Gabrielli; M T Cullen; X Z Zheng; J C Hobbins; E N Harris
Journal:  Am J Obstet Gynecol       Date:  1990-07       Impact factor: 8.661

Review 2.  Antiphospholipid syndrome: laboratory concerns, fetal loss, and pregnancy management.

Authors:  D W Branch
Journal:  Semin Perinatol       Date:  1991-06       Impact factor: 3.300

3.  Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.

Authors:  F S Cowchock; E A Reece; D Balaban; D W Branch; L Plouffe
Journal:  Am J Obstet Gynecol       Date:  1992-05       Impact factor: 8.661

4.  The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants.

Authors:  P Thiagarajan; V Pengo; S S Shapiro
Journal:  Blood       Date:  1986-10       Impact factor: 22.113

5.  Anticardiolipin antibodies, functional protein S deficiency, and fetal loss.

Authors:  A Ruffatti; L DiLenardo; P Simioni; S Tonetto; A Girolami; P Grella; S Todesco
Journal:  Am J Hematol       Date:  1995-01       Impact factor: 10.047

Review 6.  Immunologic aspects of recurrent abortion and fetal death.

Authors:  J R Scott; N S Rote; D W Branch
Journal:  Obstet Gynecol       Date:  1987-10       Impact factor: 7.661

7.  Down-regulation of maternal antiphospholipid antibodies during early pregnancy and pregnancy outcome.

Authors:  J Y Kwak; R Barini; A Gilman-Sachs; K D Beaman; A E Beer
Journal:  Am J Obstet Gynecol       Date:  1994-07       Impact factor: 8.661

Review 8.  Heparin and pregnancy in women with a history of repeated miscarriages.

Authors:  J A McIntyre; C G Taylor; D S Torry; D R Wagenknecht; J Wilson; W P Faulk
Journal:  Haemostasis       Date:  1993-03

9.  The association of antiphospholipid antibodies with pregnancies complicated by fetal growth restriction.

Authors:  W J Polzin; J N Kopelman; R D Robinson; J A Read; K Brady
Journal:  Obstet Gynecol       Date:  1991-12       Impact factor: 7.661

10.  Course of antiphospholipid antibodies in patients with primary antiphospholipid syndrome before, during and after pregnancy treated with low dose aspirin. Relationship of antibody levels to outcome in 7 patients.

Authors:  J Sánchez-Guerrero; D Alarcón-Segovia
Journal:  J Rheumatol       Date:  1992-07       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.